‘I’m Scared’: Ozempic Users Struggle as Insurers Cancel Coverage

A common feeling overwhelms people who are suddenly forced off weight-loss drugs: dread. They dread the return of an insistent appetite. They dread the drone of “food noise” growing louder. And they dread a surge in their blood-sugar levels and the relapse of physical ailments that had disappeared.

“I’m scared,” says Danielle Koehn, one of a growing number of Americans whose insurance has stopped covering her injections of Eli Lilly & Co.’s Mounjaro. “I don’t want to go back to where I was.”

Shots that cause rapid weight loss, like Lilly’s Mounjaro and Zepbound and Novo Nordisk A/S’s Ozempic and Wegovy, are ...